Cargando…

Brain derived neurotrophic factor expression and DNA methylation in response to subchronic valproic acid and/or aldosterone treatment

AIM: To test the hypothesis that valproic acid treatment positively affects brain-derived neurotrophic factor (BDNF) expression and DNA methylation in the hippocampus and brain cortex of rats simultaneously treated with aldosterone. METHODS: Male Sprague-Dawley rats (N = 40) were treated for two wee...

Descripción completa

Detalles Bibliográficos
Autores principales:	Buzgoova, Katarina, Graban, Jan, Balagova, Lucia, Hlavacova, Natasa, Jezova, Daniela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Croatian Medical Schools 2019
Materias:	International Conference on Neurological Disorders and Neurorestoration
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6509635/ https://www.ncbi.nlm.nih.gov/pubmed/31044578 http://dx.doi.org/10.3325/cmj.2019.60.71

Ejemplares similares

Neuroprotective and reparative effects of endoplasmic reticulum luminal proteins – mesencephalic astrocyte-derived neurotrophic factor and cerebral dopamine neurotrophic factor
por: Albert, Katrina, et al.
Publicado: (2019)

The European Brain Council: toward sustained and better coordinated brain research in Europe
por: Di Luca, Monica, et al.
Publicado: (2019)

Necroptosis is one of the modalities of cell death accompanying ischemic brain stroke: from pathogenesis to therapeutic possibilities
por: Hribljan, Valentina, et al.
Publicado: (2019)

Glia in amyotrophic lateral sclerosis and spinal cord injury: common therapeutic targets
por: Ban, Jelena, et al.
Publicado: (2019)

Raman microspectroscopy: toward a better distinction and profiling of different populations of dental stem cells
por: Simonović, Jelena, et al.
Publicado: (2019)

Toward earlier diagnosis and treatment of rare neurological disorders: the value of coordinated care and specialist centers
por: Giunti, Paola, et al.
Publicado: (2019)

Therapies for multiple sclerosis targeting B cells
por: Milo, Ron
Publicado: (2019)

Sex differences in early communication development: behavioral and neurobiological indicators of more vulnerable communication system development in boys
por: Adani, Shir, et al.
Publicado: (2019)

Molecular mechanisms of microglia- and astrocyte-driven neurorestoration triggered by application of electromagnetic fields
por: Isaković, Jasmina, et al.
Publicado: (2019)

Ten priorities for national brain and mental health plans
por: Mauguière, François, et al.
Publicado: (2019)

Psychotropic Drug Effects on Steroid Stress Hormone Release and Possible Mechanisms Involved
por: Romanova, Zuzana, et al.
Publicado: (2022)

Severe Pancytopenia Induced by Valproic Acid
por: Wahba, Andrew, et al.
Publicado: (2020)

Reduced Social Risk-Taking in Depression
por: Follett, Daisy, et al.
Publicado: (2023)

Selected neuroendocrine factors as potential molecular biomarkers of early non-affective psychosis course in relation to treatment outcome: A pilot study
por: Obdržálková, Marie, et al.
Publicado: (2023)

Magnetic resonance imaging of Huntington's disease: preparing for clinical trials
por: Klöppel, S., et al.
Publicado: (2009)

Prodromal Parkinsonism and Neurodegenerative Risk Stratification in REM Sleep Behavior Disorder
por: Barber, Thomas R, et al.
Publicado: (2017)

Melatonin receptor type 1A gene linked to Alzheimer’s disease in old age
por: Sulkava, Sonja, et al.
Publicado: (2018)

Screening for idiopathic REM sleep behavior disorder: usefulness of actigraphy
por: Stefani, Ambra, et al.
Publicado: (2018)

Multiple treatment comparison in narcolepsy: a network meta-analysis
por: Lehert, Philippe, et al.
Publicado: (2018)

Changes in sleep duration and the risk of incident dementia in the elderly Japanese: the Ohsaki Cohort 2006 Study
por: Lu, Yukai, et al.
Publicado: (2018)

To split or to lump? Classifying the central disorders of hypersomnolence
por: Fronczek, Rolf, et al.
Publicado: (2020)

Long-term study of the safety and maintenance of efficacy of solriamfetol (JZP-110) in the treatment of excessive sleepiness in participants with narcolepsy or obstructive sleep apnea
por: Malhotra, Atul, et al.
Publicado: (2019)

A circuit perspective on narcolepsy
por: Adamantidis, A R, et al.
Publicado: (2020)

Narcolepsy type 1: what have we learned from genetics?
por: Ollila, Hanna M
Publicado: (2020)

Automated 3D video analysis of lower limb movements during REM sleep: a new diagnostic tool for isolated REM sleep behavior disorder
por: Waser, Markus, et al.
Publicado: (2020)

Long-term use of pitolisant to treat patients with narcolepsy: Harmony III Study
por: Dauvilliers, Yves, et al.
Publicado: (2019)

Electrophysiological features of sleep in children with Kir4.1 channel mutations and Autism–Epilepsy phenotype: a preliminary study
por: Cucchiara, Federico, et al.
Publicado: (2019)

Measuring the prevalence of sleep disturbances in people with dementia living in care homes: a systematic review and meta-analysis
por: Webster, Lucy, et al.
Publicado: (2019)

Evaluation of the abuse potential of pitolisant, a selective H(3)-receptor antagonist/inverse agonist, for the treatment of adult patients with narcolepsy with or without cataplexy
por: Setnik, Beatrice, et al.
Publicado: (2019)

Association of proton pump inhibitor and histamine H(2)-receptor antagonists with restless legs syndrome
por: Earley, Eric J, et al.
Publicado: (2020)

Efficacy and safety of calcium, magnesium, potassium, and sodium oxybates (lower-sodium oxybate [LXB]; JZP-258) in a placebo-controlled, double-blind, randomized withdrawal study in adults with narcolepsy with cataplexy
por: Bogan, Richard K, et al.
Publicado: (2020)

Striatal histamine mechanism in the pathogenesis of restless legs syndrome
por: Lai, Yuan-Yang, et al.
Publicado: (2019)

Self-reported sleep relates to microstructural hippocampal decline in ß-amyloid positive Adults beyond genetic risk
por: Grydeland, Håkon, et al.
Publicado: (2021)

Sleep health and cognitive function among people with and without HIV: the use of different machine learning approaches
por: De Francesco, Davide, et al.
Publicado: (2021)

High nocturnal sleep fragmentation is associated with low T lymphocyte P2Y(11) protein levels in narcolepsy type 1
por: Viste, Rannveig, et al.
Publicado: (2021)

High national rates of high-dose dopamine agonist prescribing for restless legs syndrome
por: Winkelman, John W
Publicado: (2021)

Phase and amplitude electroencephalography correlations change with disease progression in people with idiopathic rapid eye-movement sleep behavior disorder
por: Roascio, Monica, et al.
Publicado: (2021)

Intermediate hypocretin-1 cerebrospinal fluid levels and typical cataplexy: their significance in the diagnosis of narcolepsy type 1
por: van der Hoeven, Adrienne Elisabeth, et al.
Publicado: (2022)

Once-nightly sodium oxybate (FT218) demonstrated improvement of symptoms in a phase 3 randomized clinical trial in patients with narcolepsy
por: Kushida, Clete A, et al.
Publicado: (2021)

Hypocretin-1 measurements in cerebrospinal fluid using radioimmunoassay: within and between assay reliability and limit of quantification
por: van der Hoeven, Adrienne Elisabeth, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qmile1mjnu7h1rg93qjvvl4cq9